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The successful cultivation of vaccine virus in a medium consisting 
of minced chick embryo tissue suspended in Tyrode's solution and 
the use of this virus by means of dermal inoculation for Jennerian 
prophylaxis in man have been described in previous communications 
(1, 2).  A continuation of investigations of culture vaccine virus has 
rendered possible at this time a  statement regarding the desirability 
of its intradermal use in man and a presentation of facts pertaining to 
its preservation and application. 
In an earlier report (2) the fact that the titer of our vaccine gradu- 
ally diminished during the course of successive passages in the medium 
used was recorded.  At that time there was also described a strain of 
culture virus, designated as the second revived strain, which main- 
tained a  constant titer and appeared to have become adapted to in 
vitro  cultivation.  This second revived strain has now been carried 
through 130 successive passages in chick embryo tissue and Tyrode's 
solution during a  period of 3  years and still regularly yields when 
injected intradermally into rabbits typical mild vaccinai lesions.  It 
is assumed, therefore, that serial passage in cultures may be continued 
much longer, or that by reversion to earlier cultures preserved at low 
temperatures the necessity of further rejuvenation by passage through 
animals will seldom arise. 
lntradermal  Vaccination against Smallpox 
Since the cultivation of vaccine virus in vitro has made available 
an  active agent free from bacteria and now sufficiently mild in its 
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action  to be injected  with  safety into  the  skin of human  beings,  we 
believe  that  intradermal  vaccination  deserves  serious  consideration 
as  a  means of preventing  smallpox.  The  procedure  is  quickly  and 
easily executed  and  the  amount  of material  inoculated  can  be  con- 
trolled  accurately.  The  resultant  reactions  are  characterized  by 
erythema and induration  without  the formation of an open sore and 
a  disfiguring scar.  There is,  therefore, little opportunity for the oc- 
currence of secondary infections.  The  absence of a  vaccinal  scar is 
not an undesirable feature since the presence of such a  scar is no as- 
surance  of immunity  to  smallpox.  Furthermore,  the  reactions  pro- 
duced  by intradermal  injections  of vaccine virus in  individuals  who 
have been previously vaccinated  are characteristic and more suscep- 
tible of interpretation  in terms of resistance to infection than are the 
reactions  that  follow dermal revaccination. 
Method of Intradermal Inoculation 
Routine cultures of vaccine virus after being ground in a  mortar without an 
abrasive are tested for the presence of ordinary bacteria.  Bacteria-free emulsions 
are then mixed with equal amounts of sterile glycerol and stored at a temperature 
several degrees below 0°C.  With  such material most of  our intradermal  vac- 
cinations and revaccinations have been conducted in the following manner.  0.1 co. 
of glycerolated culture virus diluted 5-10 times with sterile salt solution is injected 
into the skin of the upper arm or thigh by means of a  tuberculin syringe fitted 
with a 27 gauge needle in a manner similar to that used in making an intradermal 
tuberculin or Sckick test.  After the injection has been completed it is essential 
to cleanse the needle wound thoroughly with alcohol in order to prevent the forma- 
tion of a vesicle on the surface of the skin.  No dressing  or special care is indi- 
cated; i.e., the arm or thigh can be freely bathed throughout the evolution of the 
intradermal lesion. 
Results of Primary Intradermal Vaccinations 
In the  clinic  at  the  Hospital of The  Rockefeller  Institute there is 
no opportunity of vaccinating a  large number of people.  Neverthe- 
less, from time to time we are requested to make primary vaccinations, 
and during  the last year  and a  half 29 infants and  children  have re- 
ceived the culture virus intradermally. 
When an individual who has never had a  successful  vaccination receives the 
culture virus intradermaUy, nothing abnormal is noted at the point of inoculation 
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larger until the area of induration and erythema is 2 or 3 cm. in diameter (Fig. 1). 
At the height of the reaction, which is usuaUy 4 to 6 days after its initiation, a 
secondary zone of erythema, less intense than the primary, makes its appearance 
around the lesion, remains for a day or two, and then rapidly disappears.  The 
induration gradually becomes less marked and as a rule is no longer discernible 
3 weeks after the appearance of the lesion.  If the inoculation is made properly 
there is no vesicle formation to leave a scar. 
The 29 infants  and  children  received one intradermal  inoculation 
of the second revived strain of culture vaccine virus  (422-872  culture 
generations were  used)  that had been stored with glycerol 6  days to 
6 months.  All of them reacted with primary takes. 
19 of them were under observation to such an extent that we could determine 
the time of appearance of the lesions; 2 appeared on the 4th day after inoculation, 
2 on the 5th day, 3 on the 6th day, 5 on the 7th day, 2 on the 8th  day, 2 on the 
9th day, and 1 each on the 10th, 13th, and 17th days.  None of the children seemed 
sick as a result of the vaccinations.  While most of them showed an increase in 
the size of the axilhry lymph nodes, only 2 had fever, and in them the devation 
of temperature lasted only one day and went no higher than 101°F.  One of the 
subjects that responded with a primary take had been unsuccessfuUy vaccinated 
on 3 occasions previonsly in which calf lymph and the scratch method of inocula- 
tion had been employed. 
It has not been possible to make tests for immunity to calf lymph 
in  all  of  the  individuals  that  showed  primary  takes  resulting from 
intradermal  inoculation  of  culture  virus.  In  7  instances,  however, 
such  tests  have  been  made.  6  infants  revaccinated  dermally  with 
the  New York  City Board of Health  calf lymph,  13 days,  16 days, 
17 days, 19 days, 20 days, and 6 months, respectively, after a primary 
intradermal  vaccinal lesion  responded with  immune  reactions,  while 
1  infant  revaccinated  after a  lapse  of  7  months  responded  with  an 
accelerated take. 
Results of Revaccination  by the Intradermal Method 
Revaccinations by means of calf lymph applied dermally result in 
immediate  or immune  reactions,  or in  accelerated  takes.  Most  in- 
vestigators admit, however, that it is difficult to differentiate an im- 
mune reaction from no reaction, because trauma  alone incident to a 
dermal vaccination induces a  certain amount of reaction that leads to 
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intradermal injections of culture virus in  individuals previously suc- 
cessfully vaccinated would yield distinct and unmistakable immune 
reactions  or  accelerated  takes.  If  such  reactions  regularly occur, 
then  the absence of vaccinal scars  would not be  a  valid reason for 
opposing intradermal vaccination, because within  a  short  time one 
could determine whether an individual is immune to vaccinia or not. 
33 individuals, 1 to 65 years of age, who had been successfully  vaccinated one 
or more times with calf lymph, received intradermal injections of culture vaccine 
virus similar to those used for primary inoculations.  All of them, with the excep- 
tion of 2, responded with reactions comparable either to the immune reactions or 
to the accelerated takes that follow dermal revaccinations.  The earliest reaction 
to occur appeared within 6 hours after inoculation, while others did not become 
evident until 2 or 3 days later.  Those that appeared rapidly consisted of small 
red papules accompanied by itching and disappeared in a day or two.  The ones 
that developed more slowly were larger than the others, endured for 3 or 4 days, 
and gradually disappeared to be followed  by a slight desquamation of the involved 
skin. 
The fact that no reactions were observed until from 4  to 17 days 
after primary intradermal inoculations of the culture virus led us to 
believe that the immediate and accelerated reactions encountered in 
revaccinated people were specific for vaccinia.  To test the specificity 
of the reactions further, uninoculated media incubated and handled 
in a manner similar to that of the cultures were in many instances in- 
jected as  a  control when  the  revaccinations were made.  None  of 
the control injections produced demonstrable reactions.  At this time 
it is of interest to record the fact that cultures of vaccine virus passed 
through filters which retain all of the infectious agent contain a soluble 
antigen  that  is  innocuous for the  skin  of unvaccinated people but 
capable of producing a  reaction in the skin of individuals immune to 
vaccinia,  while  filtrates  of  uninoculated  media  cause  no  obvious 
changes in the skin of either group. 
Preservation of Culture  Virus 
Culture  vaccine  virus  stored  in  50  per  cent  glycerol retains  its 
activity for several years and can be used for vaccination or the initia- 
tion of cultures.  Such virus, however, does not remain active in the 
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tribution of the active agent by mail.  In view of the fact that many 
viruses desiccated in a  frozen state retain their activity under condi- 
tions ordinarily deleterious, we have attempted to obtain preparations 
of desiccated  culture vaccine virus  that  are  suitable  for human use 
and  retain their activity for considerable periods of time in  the  ab- 
sence of refrigeration. 
Some results  obtained  with  desiccated  culture vaccine virus have 
already  been  described  (2).  However,  experience  has  shown  that 
when such virus is dried in small amounts in glass tubes difficulty is 
encountered in removing the active agent from the containers.  The 
virus apparently adheres to the walls of the tubes to such an  extent 
that when fluid is added and the material from each of several tubes 
of the same batch is titrated in the skin of the same rabbit uniform 
results are not realized.  Therefore, it became necessary to add to the 
culture  virus  some  sterile  innocuous  substance  that  would  act  as  a 
protective  agent,  add  bulk  to  the  dried  preparations,  and  go  into 
solution or become suspended  with  ease upon  the  addition  of fluid. 
Egg albumen was the material investigated first. 
Preservation of Culture Vaccine Virus in the Presence of Egg 
Albumen 
Mixtures  of  culture  virus  and  egg  albumen  were  desiccated  and 
handled in  the  following manner. 
3  parts  of culture virus, ground in  a  mortar without an abrasive until the 
particles of tissue are finely dispersed, are thoroughly mixed with 1 part of sterile 
egg albumen.  The mixture is  then distributed in 0.25  cc. amounts into small 
sterile test tubes, frozen rapidly by means of solid COs in alcohol, and placed in 
a refrigerating box at  -4°C. in the presence of CaCh.  Air is evacuated from the 
box by means of a Cenco-Hyvac pump, and throughout the period of desiccation 
the pressure in  the box is maintained at  approximately 1-2 mm.  of mercury. 
Drying of the virus and  egg  albumen  occurs  rapidly.  The tubes  are usually 
allowed to remain in the box for 24 hours after which they are removed and placed 
• in a desiccator at room temperature.  When the tubes have returned to the tem- 
perature of the room they are removed from the desiccator and quickly sealed 
in a hot flame.  The dried material appears as white foam-llke peUets which can 
be freed with ease from the sides of the tubes and pulverized.  It is readily miscible 
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A  number  of  samples  of  culture  virus  have  been  dried  with  egg 
albumen and have been shown to retain their activity for considerable 
periods  of  time  when  held  at  room  temperature.  One  experiment, 
summarized in  Table I,  showed by intradermal  tests in rabbits  that 
the virus kept under such  conditions for 3½ months was  still active. 
Desiccated mixtures of culture virus and egg albumen may be used 
for dermal  vaccination of human  beings. 
A tube is opened aseptically, the dried material is pulverized in the container, 
a small amount of the powder is taken up on the end of a sterile wooden applicator 
and is rubbed on a scarified area of skin of the upper arm or thigh.  The moist 
serous  exudate resulting from the scarification  dissolves  the powder sufficiently 
TABLE I 
Record of Intradermal Titrations in Rabbits of Vaccine Virus, Culture 662, Desiccated 
with Egg Albumen and Stored at Room Temperature 
Time of titration  Titer  of virus 
Before desiccation:  ........................................... 
Immediately after desiccation  .................................. 
5 days  "  "  .................................. 
16 days  "  "  .................................. 
1 too.  "  "  .................................. 
2 mos.  "  "  .................................. 
3½ mos.  "  "  .................................. 
10-~ 
10-5; IO-G 
10-s 
10-6 
I0-~ 
10-4 
10-3 
to cause it to adhere to the skin.  The evolution of the vaccinal lesions induced 
in this way is normal and similar to that caused by moderately potent commercial 
vaccine virus. 
Eleven  of  12  children  who  received  dermal  applications  of  the 
virus dried with egg albumen responded with typical primary takes. 
One of them was sensitive to the albumen and a large urticarial lesion 
developed almost immediately at  the  site of inoculation.  This dis- 
appeared,  however,  and  the  evolution  of  the  vaccinal  lesion  was 
entirely normal. 
Egg white is a  highly antigenic  substance.  In  view of this  fact, 
although the use of mixtures of virus and albumen for dermal vaccina- 
tion is  not  attended  by harmful  results  even in  individuals  already 
sensitive  to  egg  white,  one  hesitates  to  advocate  the  use  of  such THOMAS  M.  RIVERS  AND  S.  M.  WARD  555 
preparations for intradermal vaccination.  Inasmuch as we were par- 
ticularly interested in developing a  method of preserving the culture 
virus  for intradermal  use  in  human  beings,  we  sought  for harmless 
non-antigenic substances  that would protect the  active agent  during 
the processes of drying and  resuspension.  Purified gum  acacia  has 
been found to act satisfactorily. 
Preservation of Culture Vaccine Virus in the Presence of Purified 
Gum Acacia 
A  30 per cent solution of gum acacia, purified for intravenous ad- 
ministration,  was  obtained from Eli Lilly and  Co.  Intradermal  in- 
jections  of  this  material  in  concentrations  as  high  as  7.5  per  cent 
caused no perceptible reactions in human beings.  Mixtures of culture 
virus and acacia were desiccated with ease, and when dry they went 
back into solution readily upon  the addition of water or saline solu- 
tion.  It appeared  that  we had found an  ideal means Of preserving 
the virus with the exception that the apparatus used for freezing and 
drying necessitated the exposure of the desiccated material to atmos- 
pheric pressure and moisture before the containers were sealed.  We 
were  aware,  therefore,  that  a  method  of  desiccation  which  would 
permit the containers of the dried product to be sealed while under a 
vacuum  would  be  an  improvement.  Recently,  Mudd  and  his  as- 
sociates (3, 4) have described an apparatus designed for this purpose, 
and we have adapted it to the preservation of our culture virus. 
The Mudd apparatus (Fig. 2) used by us consists of a cylindrical glass bulb to 
which on one side near the top is fused in a horizontal position a long hollow glass 
side arm or manifold with 24 apertures.  On the opposite side, the bulb is attached 
by a short side arm and rubber stopper to a trap which in turn is connected by 
pressure  tubing  to  a  Cenco-Hyvac pump.  The bulb and trap are placed in a 
mixture of solid CO2 and alcohol in a thermos jug.  The material to be dried is 
frozen in pyrex glass containers which are then suspended from the apertures of 
the side arm or manifold by means of units consisting of rubber tubing, glass tub- 
ing,  and a hollow rubber cork.  Then the pressure  in the apparatus is reduced 
rapidly to a low level, the material to be dried remains frozen, and the moisture 
drawn from the containers condenses in the large bulb immersed in the freezing 
mixture.  The containers of the dried virus are sealed, while the vacuum pump 
is still running, by means of a torch equipped with 2 tips opposing each other and 
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The  method  which  we  now  use  for  the  preservation  of  culture 
vaccine  virus  to  be  employed  for vaccination of human  beings  is  as 
follows. 
1 part of a sterile 30 per cent solution of gum acacia is mixed with 11 parts of 
culture virus which has been ground in a  mortar without an abrasive until  the 
particles of tissue are finely dispersed.  0.4 or 0.8 ce. of the mixture are placed in 
each of a  number of ampoules.  The ampoules, blown from pyrex glass tubing 
with  an  internal  diameter  of approximately  5  mm.,  have  necks about  8.5  cm. 
in length, fiat bottoms, and a capacity of at least 2 cc.  The virus is placed in the 
ampoules by means of a syringe with a long needle, after which the neck of each 
ampoule is inserted into one end of a  short piece of pressure gum rubber tubing 
the other end of which receives an arm of a  short piece of glass tubing bent to 
form a right angle.  The other arm of the glass tube passes through a gum rubber 
stopper that fits an opening in the manifold of the drying apparatus.  Each time 
before they are used, the bent glass tubes, with one arm pushed through its hollow 
rubber  stopper and closed by a  gauze plug and the other arm inserted into its 
short piece of rubber tubing,  are wrapped separately  in paper  and sterilized  in 
an autoclave.  After 24 units consisting of ampoules, rubber tubing, glass tubing, 
and stoppers have been assembled in the manner described the contents of the 
ampoules are frozen by immersion in a mixture of solid CO2 and alcohol.  Then 
the  units  are  rapidly  connected with  the  drying apparatus  by insertion  of the 
rubber stopper of each unit into an aperture of the manifold after removal of the 
gauze plug from the end of the glass tube.  The vacuum pump is  started  im- 
mediately, and within a  few minutes the outer surface of the ampoules becomes 
covered with frost  which gradually evaporates as  desiccation proceeds.  Desic- 
cation is completed within 5 or 6 hours, and the necks of the ampoules are then 
sealed by means of an oxygen torch while the vacuum pump is still running. 
When the dried material is desired for use an ampoule is opened and 2 cc. of 
sterile  water or saline solution is added by means of a  syringe and needle.  In 
this manner a  1 to 2.5 or a  1 to 5 dilution of the virus is effected depending on 
whether 0.8 cc. or 0.4 cc. of virus have been placedin the ampoules before desicca- 
tion.  The 1 to 2.5 or 1 to 5 dilutions of the virus may be used for intradermal 
vaccination of human beings, or by means of further dilutions they may be used 
for intradermal titrations in rabbits. 
In  view  of previous  experiences  we  have  assumed  that  the  virus 
dried  in  the presence of acacia will  remain  active for long periods  of 
time when stored at low temperatures.  However, we wanted to know 
definitely  whether  it  would  retain  its  activity  under  conditions  en- 
countered  during  transportation  requiring  several  days  or  weeks. 
Consequently,  we have  tested  numerous  batches  of the dried  culture THOMAS  M.  RIVERS  AND  S.  M.  WARD  557 
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virus that had been stored at  37°C.  for 2  and 4  weeks.  From  the 
results of the experiments, summarized in Table II, it is obvious that 
the dried virus retains its activity remarkably well under such con- 
ditions. 
We have been able to vaccinate and revaccinate only a few people 
with mixtures of virus and acacia.  In every instance, however, the 
intradermal inoculation of the material resulted in primary reactions, 
accelerated takes, or immune responses. 
Inasmuch as we are in no position to vaccinate a  large number of 
people, the dried mixture of culture virus and acacia is being supplied 
to a group of physicians who will determine the rapidity of appearance 
and  duration of immunity resulting from its  intradermal use.  Al- 
ready more than a thousand individuals have been vaccinated and in 
the course of time reports concerning the value of intradermal vac- 
cination with the culture virus will appear in the literature. 
DISCUSSION 
Intradermal vaccination of human beings against smallpox has been 
tried by a  number of investigators and Roberts  (5)  has recently re- 
viewed the literature on the subject.  It should be clearly understood 
that we are not advocating the intradermal use of ordinary calf lymph 
or  cultures  of  vaccine virus  recently initiated  from  calf lymph  or 
other sources, because such materials (1,  5) used intradermally may 
result in more severe constitutional disturbances and damages to the 
tissues at the site of inoculation than those caused by their dermal ap- 
plication.  Although our culture virus came originally from the New 
York City Board of Health calf lymph it is free from ordinary bacteria 
and has now been propagated  for such a length of time in vitro  that 
mild reactions are regularly produced when it is injected intradermally 
in rabbits and human beings. 
Our second revived strain of culture virus can be used with safety 
for intradermal vaccination of human beings, and when handled prop- 
erly it induces a high percentage of takes which are followed within 
a  reasonable length of time by an immunity to  a  standard dermal 
strain  of vaccine virus.  Consequently,  we  are  convinced that  the 
intradermal use of culture virus should be seriously considered as a 
method  to  be  employed  more  extensively  for  protection  against 
smallpox. THOMAS  M.  RIVERS  AND  S.  M.  WARD  559 
Knowledge concerning the duration of immunity produced by the 
culture virus is not available yet.  Nevertheless, this will be obtained 
gradually.  When the facts regarding the matter are presented, in- 
vestigators and physicians should not be surprised to find that a certain 
number of  successfully vaccinated individuals  will  have lost  their 
immunity within a period of a year.  At least that is the case with 
people who have been successfully vaccinated for the first time with 
calf lymph.  For instance,  Kitasato  (6)  found that  13.3 per  cent 
of people successfully vaccinated with calf lymph were again suscep- 
tible  a  year later.  Donnally and Nicholson  (7),  using a  standard 
calf lymph, vaccinated 500 infants at birth.  Fifty-two of the success- 
fully vaccinated babies were revaccinated at from 13 to 16 months of 
age, and 30.8 per cent of them again exhibited primary takes.  The 
facts just mentioned are not generally appreciated and indicate that 
in  many countries revaccinations are not practiced with  sufficient 
frequency and regularity. 
It may be found that the immunity induced by one intradermal 
inoculation of culture virus will not be as enduring as that produced 
by potent calf lymph.  If such proves to be the case, the advantages 
of the intradermal method of administration are so obvious and the 
amount of reaction and inconvenience caused by the culture virus is 
so inconsequential that two or more intradermal inoculations, made 
at the same time in different areas of skin, or more frequent revac- 
cinations may meet with general favor as means of prolonging or re- 
newing an immunity to smallpox. 
This discussion  should not be concluded without calling attention 
to the fact that the direct evidence in our possession only shows that 
the culture virus will prevent an infection with  calf lymph.  Such 
evidence leads us to believe that individuals vaccinated with culture 
virus are protected against smallpox.  We cannot be absolutely cer- 
tain that this is true, however, until people vaccinated with the culture 
virus have been exposed to smallpox. 
CONCLUSIONS 
The second revived strain of culture vaccine virus has been propa- 
gated through 130  culture passages during a period of 3 years.  It 
seems to be adapted to in vitro cultivation and still has an intradermal 
titer (rabbits) of 1 to  100,000 or 1 to  1,000,000. 560  INTRADERMAL USE  OF  CULTURE VACCINE VIRUS 
Intradermal inoculations in human beings of 0.1  cc.  amounts of 
culture virus diluted from 2.5  to 10 times result in primary takes in 
unvaccinated people and immune reactions or accelerated takes in 
individuals previously successfully vaccinated.  Primary takes pro- 
duce an immunity to standard strains of calf lymph. 
Culture virus mixed with purified gum acacia (2.5 per cent), frozen, 
desiccated, and  sealed i~ va~uo retains  its activity for a  month at 
37°C., and when the dried virus is resuspended in saline solution it 
is suitable for intradermal vaccination of human beings. 
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EXPLANATION  OF PLATE 25 
FIG. 1.  Reaction produced in the skin of a young child by culture vaccine virus 
introduced intradermally.  The lesion  made its appearance 10 days after inocu- 
lation and was photographed 2 days later. 
FIo.  2.  The  Mudd-Flosdorf  drying  apparatus  used  in  the  preservation  of 
culture vaccine virus to be employed for intradermal vaccination of human beings. 
The tubes containing the virus are closed at the distal end with rubber stoppers. 
Later we decided that glass containers constructed so that rubber stoppers would 
not be needed are preferable. THE JOURNAL OF EXPERIMENTAL  MEDICINE VOL. 62  PLATE 25 
Photographed by Joseph  B. Haulenbeek 
(Rivers and Ward: Intradermal use of culture vaccine virus) 